Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Huapont Life Science Co's Total Liabilities for the quarter that ended in Jun. 2026 was ¥11,991 Mil.
Huapont Life Science Co's quarterly Total Liabilities
increased
from Dec. 2025 (¥11,554.82 Mil) to Mar. 2026 (¥12,494.94 Mil) but then
declined
from Mar. 2026 (¥12,494.94 Mil) to Jun. 2026 (¥11,990.68 Mil).
Huapont Life Science Co's annual Total Liabilities
declined
from Dec. 2023 (¥13,682.98 Mil) to Dec. 2024 (¥13,521.74 Mil) and
declined
from Dec. 2024 (¥13,521.74 Mil) to Dec. 2025 (¥11,554.82 Mil).
Huapont Life Science Co Total Liabilities Related Terms
Huapont Life Science Co Total Liabilities Historical Data
* Premium members only.
The historical data trend for Huapont Life Science Co's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Huapont Life Science Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of ¥11,991 Mil mean?
Huapont Life Science Co (SZSE:002004) has a Total Liabilities of ¥11,991 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Huapont Life Science Co and its competitors.
Is Huapont Life Science Co's Total Liabilities too high?
Huapont Life Science Co's current Total Liabilities is ¥11,991 Mil. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's Total Liabilities compare to CTVA and CF?
Huapont Life Science Co's Total Liabilities of ¥11,991 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for an Agriculture company?
A good Total Liabilities depends on the Agriculture industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Huapont Life Science Co and its competitors. Huapont Life Science Co's current Total Liabilities is ¥11,991 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current Total Liabilities is ¥11,991 Mil. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current Total Liabilities is ¥11,991 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?
Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued.
The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43.
GuruFocus considers Huapont Life Science Co to be Fairly Valued.
Key valuation signals for SZSE:002004:
Total Liabilities: ¥11,991 Mil
GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score
Get the complete analysis for SZSE:002004
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002004 has been successfully added to your 
